I just had the opportunity to attend this year’s American Society of Gene & Cell Therapy (ASGCT) annual meeting — one of my favorite conferences o…

At Vertex, we believe the most important medicines are those that have transformative impact for patients. And while drug discovery and development ar…

I remember first learning about CRISPR years ago and thinking, “this technology could really work.” At the time, I didn’t realize that I would get to …

This year, Vertex turns 30. For three decades, some of the best and brightest minds in science and medicine – known around here as ‘Vertexians’ – …

As CEO of Vertex since 2012, I’ve had the privilege of building personal connections with many different people in the cystic fibrosis (CF) community …